SKSeyed Mahdi Banan Khojasteh

Seyed Mahdi Banan Khojasteh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seyed Mahdi Banan Khojasteh has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nicotine Administration Exacerbates Lipid Profile Alterations in a Wistar Rat Model of Liver Fibrosis through Fatty Acid Synthesis Modulation

    by Narges Dastmalchi, Khalil Hajiasgharzadeh, Hooria Amooji, Mohammad Reza Alipour, Behzad Mansoori, Homeira Hatami Nemati, Seyed Mahdi Banan Khojasteh

    Dyslipidemia is characterized by abnormal lipid levels in the bloodstream and can be influenced by liver diseases and smoking. Nicotine exposure and liver damage are linked to lipid metabolism impairments. This study investigated the effects of nicotine on dyslipidemia in a cholestasis rat model using bile duct ligation (BDL) to establish liver fibrosis. Wistar rats received intraperitoneal nicotine at doses of 10 mg/kg (high) and 1 mg/kg (low) for three weeks. Serum levels of triglycerides (TG), cholesterol (Chol), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were quantified via a standard colorimetric kit (Pars Azmoon). Liver fibrosis confirmed through histological investigation. Additionally, the mRNA and protein expression of fatty acid synthase (FAS) were assessed using quantitative RT-PCR and immunofluorescence. Results showed that nicotine administration in healthy rats significantly increased TG, Chol, and LDL levels while decreasing HDL. In BDL rats, nicotine further reduced HDL and increased TG levels without affecting Chol and LDL. Histological analysis confirmed hepatic fibrosis, and both nicotine exposure and liver fibrosis elevated FAS expression in liver tissues. These findings indicate that BDL-induced liver fibrosis causes dyslipidemia in rats, and nicotine exposure exacerbates serum lipid profile alterations, potentially through increased FAS expression. Therefore, it is recommended that individuals with liver disease avoid nicotine to manage dyslipidemia.

  • Open Access

    Investigating the effect of trans-anethole on the expression changes of TNF-α, resistin, and chemerin genes in visceral adipose tissue caused by estradiol valerate injection in female wistar rats

    by Mahsa Dindar, Seyed Mahdi Banan Khojasteh, Hatam Ahmadi, Homiera Hatami Nemati, Fariba Mahmoudi

    Background. Polycystic ovary syndrome (PCOS) is one of the endocrine diseases of the reproductive system, with a prevalence of 5‒10% in women, and one of its symptoms is an increase in the serum amount of pro-inflammatory adipokines from adipose tissue. Methods. This study was performed on six groups of 6 female rats, including a sham group, an estradiol valerate experimental group that received a concentration of 2 mg per kg of estradiol valerate, and two trans-anethole experimental groups that received concentrations of 50 mg/kg and 80 mg/kg of trans-anethole. The other groups were two experimental groups of estradiol valerate treated with trans-anethole that received concentrations of 50 mg/kg and 80 mg/kg of trans-anethole 60 days after receiving estradiol valerate. The data were statistically analyzed with a one-way analysis of variance and Tukey’s post hoc test via SPSS. Results. Increased expression of tumor necrosis factor-alpha (TNF-α), chemerin, and resistin genes in the visceral fat tissue of rats caused by the intramuscular injection of estradiol valerate was reduced by the intraperitoneal injection of concentrations of 50 mg/kg and 80 mg/kg of trans-anethole (P < 0.05). Conclusion. Trans-anethole ameliorated the expression of TNF-α, chemerin, and resistin genes in the visceral fat tissue of female rats suffering from PCOS. Practical Implications. The use of trans-anethole as an extract of anise and fennel may be effective in reducing the inflammatory complications of women with PCOS.

  • In Vitro Nicotine Exposure Induces microRNA-124 and Suppresses STAT3 Expression through the Alpha-7 Subtype of Nicotinic Acetylcholine Receptors in the SW-480 Cell Line

    by Khalil Hajiasgharzadeh, Behzad Baradaran, Narges Dastmalchi, Nasim Rahimi Farsi, Bahram Hashemzadeh, Mohammad Amin Doustvandi, Nadia Allahyarzadeh Khiabani, Homeira Hatami Nemati, Seyed Mahdi Banan Khojasteh

    Nicotine is an alkaloid compound commonly found in tobacco smoke. This compound, as an agonist of nicotinic acetylcholine receptors (nAChRs), binds to these receptors and induces many downstream intracellular signaling pathways. Numerous studies have shown that nicotine leads to changes in the expression of microRNAs (miRs). Among these miRs, miR-124 is an essential post-transcriptional regulator of several cancer-related and inflammatory genes expression. The present study aimed to investigate the nicotine‑induced effects on miR-124 expression in colon cancer cell lines. First, the SW-480 colon carcinoma cell line was inoculated in 6-well plates to determine the effects of treatments with low and high concentrations of nicotine (1 and 10 μM) on the expression level of miR-124 and α7-subtype of nAChR (α7nAChR) and STAT-3 by quantitative real-time PCR. Next, the electroporation method was used to transfer specific siRNA targeting α7nAChR expression after identification of the optimum dose (60 nM) and time (48 h) of α7nAchR-siRNA. Following that, the changes in the expression of miR-124, α7nAChR, and STAT-3 were measured after transfection of the α7nAchR-siRNA in combination with nicotine treatment. The findings showed that nicotine increases the expression of both miR-124 and α7nAChR and decreases the STAT-3 mRNA expression. Transfection with α7nAChR-siRNA prevents the observed effects of nicotine which indicates that these effects of nicotine are α7nAChR dependent. Nicotine alters miR-124 expression in the SW-480 cell line and exerts its effects through the α7nAChR/miR-124/STAT-3 axis. Studying the exact molecular mechanism of nicotine signaling can be useful both in diagnosing and treatment of nicotine-related diseases and finding novel potential therapeutic benefits.


  • Open Access

    Time-Series analysis of short-term exposure to air pollutants and daily hospital admissions for stroke in Tabriz, Iran

    by Shahryar Razzaghi, Saeid Mousavi, Mehran Jaberinezhad, Ali Farshbaf Khalili, Seyed Mahdi Banan Khojasteh

    Background: Air pollution is considered one of the risk factors for stroke prevalence in the long term and incidence in the short term. Tabriz is one of the most important industrial cities in Iran. Hence, air pollution has always been one of the main concerns in environmental health in the region. Method: The patient data were retrieved from electronic health records of the primary tertiary hospital of the city (Imam Reza Hospital). Air pollution data was obtained from the Environmental Protection Agency and is generated by 8 sensor stations spread across the city. Average daily values were calculated for CO, NO, NO, NOx, O3, SO2, PM2.5, and PM10 from hourly measurement data. Autoregressive integrated moving average (ARIMA-X) model with 3 lag days was developed to assess the correlation. Results: Air pollutants and hospital admission data were collected for 1821 day and includes 4865 stroke cases. our analysis showed no statistically significant association between the daily concentrations of CO (p = 0.41), NOx (p = 0.96), O3 (p = 0.65), SO2 (p = 0.91), PM2.5 (p = 0.44), and PM10 (p = 0.36). Only the binary COVID variable which was used to distinguish between COVID-19 era and other days, was significant (p value = 0.042). The goodness of fit measures, Root Mean Squared Error (RMSE), and Median Absolute Error (MAE) were 1.81 and 1.19, respectively. Conclusion: In contrast to previous reports on the subject, we did not find any pollutant significantly associated with an increased number of stroke patients.


  • Three possible diagnostic biomarkers for gastric cancer: miR-362-3p, miR-362-5p and miR-363-5p

    by Zahra Hassanpour Aydinlou, Ali Rajabi, Ali Emami, Samaneh Tayefeh-Gholami, Shahram Teimourian, Mirsaed Miri Nargesi, Seyed Mahdi Banan-Khojasteh, Reza Safaralizadeh

    Aim: MicroRNAs can be regarded as biomarkers for gastric cancer (GC) diagnosis in the early stages. This study assesses the expression levels of miR-362-3p, miR-362-5p and miR-363-5p as potential biomarkers for GC. Materials & methods: The expression levels of the miRNAs in 90 pairs of GC and adjacent normal tissue samples were analyzed by quantitative real-time reverse transcription PCR (qRT-PCR) and some bioinformatics tools were utilized for analyzing the target genes and possible molecular pathways in which these miRNAs participate. Results & conclusion: There was a significant overexpression of the miRNAs in GC cells and an outstanding correlation between their overexpression with some clinicopathological features of the patients.


  • An Updated Review of the Cross-talk Between MicroRNAs and Epigenetic Factors in Cancers

    by Narges Dastmalchi, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, Mohammad Reza Sam, Saeid Latifi-Navid, Bashdar Mahmud Hussen, Mahdi Abdoli Shadbad, Behzad Baradaran

    Background: Growing evidence indicates that miRs have critical activities in adjusting cellular processes, e.g., cell death, proliferation, and cell-cycle. Introduction: This study aimed to provide a concise review of the recent findings regarding tumoral miRs and the cross-talk between miRs and epigenetic factors. Results: Like the protein-coding genes, the expression levels of miRs are mediated by various transcriptional networks. Indeed, the expression of miRs could be epigenetically modulated by DNA methylation factors and histone modifiers. Furthermore, miRs can suppress critical factors, which mediate epigenetic modifications. Besides, miRs have been implicated in cancer development, metastasis, and chemo-resistance. The aberrant expression of miRs and dysregulated modulatory circuits between miRs and epigenetic factors participate in tumor progression. Conclusion: Identifying tumoral miRs can provide ample opportunity to overcome chemo- resistance and bring a forefront treatment for affected patients.


  • MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation

    by Narges Dastmalchi, Reza Safaralizadeh, Mohammad Ali Hosseinpourfeizi, Behzad Baradaran, Seyed Mahdi Banan Khojasteh

    Combination therapy has been considered as a potential method to overcome the BC chemoresistance. MicroRNAs (miRs) have been suggested as a therapeutic factor in the combination therapy of BC. This project aimed at examining the possible activity and molecular function of miR-424-5p and Taxol combination in the human BC cell line. MDA-MB-231 cells were treated with miR-424-5p mimics and Taxol, in a combined manner or separately. We used the MTT test for assessing the cell proliferation. In addition, flow-cytometry was used for evaluating apoptosis and cell-cycle. Expression levels of underlying molecular factors of miR-424-5p were assessed using western-blotting and qRT-PCR. The obtained results demonstrated that miR-424-5p repressed BC cell proliferation and sensitized these cells to Taxol treatment through the induction of apoptosis. Further investigations showed that miR-424-5p might increase BC chemosensitivity through the regulation of apoptosis-related factors including P53, Caspase-3, Bcl-2, and Bax as well as the proliferation-related gene c-Myc. Moreover, miR-424-5p restoration in combination with Taxol treatment decreased the colony formation by regulating Oct-4 and led to G2 arrest via modulating Cdk-2 expression. Western-blotting demonstrated that miR-424-5p may perform its anti-chemoresistance role by regulating the PD-L1 expression and controlling PTEN/PI3K/AKT/mTOR. Overall, the upregulation of miR-424-5p was indicated to upregulate the sensitivity of BC cells to treatment with Taxol. MiR-424-5p might regulate the chemosensitivity of the BC cell line by modulating PD-L1 and controlling the PTEN/mTOR axis. Therefore, the combination of miR-424-5p with Taxol would represent a novel procedure to treat against BC. Graphic abstract


  • miR‐424: A novel potential therapeutic target and prognostic factor in malignancies

    by Narges Dastmalchi, Behzad Baradaran, Seyed Mahdi Banan Khojasteh, Mohammadali Hosseinpourfeizi, Reza Safaralizadeh

    MicroRNAs are endogenous, noncoding RNAs. Showing both tumor‐suppressive and oncogenic characteristics, miRNAs can regulate important processes in malignancies. This review aimed at highlighting the recent studies on the contribution of miR‐424 to the modulation of carcinogenesis and exploring its probable clinical effectiveness in the diagnosis and therapy of malignancies. The data were extracted from all papers published from 2013 until 2020. Mature miR‐424 leads to the degradation of its target transcripts or the suppression of translation via binding to the molecular targets. miR‐424 is involved in modulating p53, PI3K/Akt, Wnt, and other molecular pathways, thereby regulating cellular growth, apoptosis, differentiation, chemoresistance, and cancer immunity. miR‐424 was introduced as a tumor‐suppressive miR in numerous types of cancers while as an oncogene in several cancers. Regarding the cancer dependent role of miR‐424, it may be a prognostic and diagnostic biomarker and a potential candidate for the treatment of cancers.


  • Antioxidants with two faces toward cancer

    by Narges Dastmalchi, Behzad Baradaran, Saeid Latifi-Navid, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, Mohammad Amini, Elmira Roshani, Parisa Lotfinejad